Secreted phospholipase A2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures

被引:42
|
作者
DeCoster, MA
Lambeau, G
Lazdunski, M
Bazan, NG
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA
[2] CNRS, Inst Mol & Cellular Pharmacol, UPR 411, F-06560 Valbonne, France
关键词
glutamate; secreted phospholipase A(2); cortical neurons; hippocampal neurons; cell death; calcium imaging; confocal microscopy;
D O I
10.1002/jnr.10131
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Secreted phospholipases A(2) (sPLA(2)s) modulate neuronal survival and neurotransmitter release. Here we show that sPLA(2) (group III) synergistically increases glutamate-induced cell death and intracellular calcium ([Ca2+](i)) in cultured primary cortical and hippocampal neurons. Whereas 1 muM glutamate elicited transient [Ca2+](i) increases in all neurons that recovered 66% to baseline, 25 ng/ml sPLA(2) pretreatment resulted in sustained [Ca2+]i increases, with only 5% recovery. At 250 nM glutamate, 25% of neurons failed to respond, and the average recovery time was 101 +/- 12 sec; sPLA(2) increased recovery time to 158 +/- 6 sec, and only 2% of cells failed to respond. Both the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 and the calcium-channel blocker cobalt inhibited this effect. Experiments with the glutamate uptake inhibitor L-trans-pyrollidine-2,4-dicarboxylic acid (2.5 muM) indicated that glutamate uptake sites are not a likely modulation point by sPLA(2), whereas arachidonic acid (AA) potentiated calcium responses to glutamate. Thus the enhancement of glutamate-induced [Ca2+]i increases by sPLA(2) may be due to modulation at NMDA receptors and/or calcium channels by AA. These results indicate that sPLA(2) affects neuronal responses to both nontoxic (0.1-10 muM) and toxic (=25 muM) concentrations of glutamate, implicating this enzyme in neuronal functions in pathology. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:634 / 645
页数:12
相关论文
共 50 条
  • [1] Secretory phospholipase A2 potentiates glutamate-induced rat striatal neuronal cell death in vivo
    Kolko, M
    Bruhn, T
    Christensen, T
    Lazdunski, M
    Lambeau, G
    Bazan, NG
    Diemer, NH
    NEUROSCIENCE LETTERS, 1999, 274 (03) : 167 - 170
  • [2] Secretory phospholipase A2 (sPLA2) enhances glutamate-induced cell death and calcium increase in primary cortical neurons.
    DeCoster, MA
    Bazan, NG
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S12 - S12
  • [3] Aluminum potentiates glutamate-induced calcium accumulation and iron-induced oxygen free radical formation in primary neuronal cultures
    Mundy, WR
    Freudenrich, TM
    Kodavanti, PRS
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1997, 32 (1-3) : 41 - 57
  • [4] Serum prevents glutamate-induced mitochondrial calcium accumulation in primary neuronal cultures
    Dux, E
    Oschlies, U
    Uto, A
    Kusumoto, M
    Siklos, L
    Joo, F
    Hossmann, KA
    ACTA NEUROPATHOLOGICA, 1996, 92 (03) : 264 - 272
  • [5] Docosahexaenoic acid affects glutamate-induced cell death in primary cortical cultures
    Calvert, GR
    Thompson, KSJ
    Martin, KF
    Heal, DJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 : U131 - U131
  • [6] LACK OF CORRELATION BETWEEN GLUTAMATE-INDUCED DEPLETION OF ATP AND NEURONAL DEATH IN PRIMARY CULTURES OF CEREBELLUM
    MARCAIDA, G
    MINANA, MD
    GRISOLIA, S
    FELIPO, V
    BRAIN RESEARCH, 1995, 695 (02) : 146 - 150
  • [7] Spatio-temporal analysis of the role of calcium in glutamate-induced neuronal cell death
    Kato, K
    Li, J
    Morita, I
    Murota, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 181P - 181P
  • [8] Group III secreted phospholipase A2 causes apoptosis in rat primary cortical neuronal cultures
    DeCoster, MA
    BRAIN RESEARCH, 2003, 988 (1-2) : 20 - 28
  • [9] Calcineurin and mitochondrial function in glutamate-induced neuronal cell death
    Ankarcrona, M
    Dypbukt, JM
    Orrenius, S
    Nicotera, P
    FEBS LETTERS, 1996, 394 (03): : 321 - 324
  • [10] Glutamate-induced neuronal cell death in cerebral infarction.
    Matsumoto, M
    JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 1996, 18 (06): : 459 - 464